Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fibrin D-dimer and cardiovascular risk.

Gordon D O Lowe1

  • 1Division of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.

Seminars in Vascular Medicine
|November 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations between plasma levels of coagulation factors VIII and IX and incident cardiovascular disease and mortality: systematic review and meta-analysis.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Plasma viscosity, immunoglobulins and risk of cardiovascular disease and mortality: new data and meta-analyses.

Journal of clinical pathology·2023
Same author

Associations of Hemostatic Variables with Cardiovascular Disease and Total Mortality: The Glasgow MONICA Study.

TH open : companion journal to thrombosis and haemostasis·2022
Same author

Haematological variables and risk of future venous thromboembolism in the British Regional Heart Study on men. Combined D-dimer and APTT as a predictive test for thromboembolism?

British journal of haematology·2022
Same author

Cardiovascular Risk Factors Associated With Venous Thromboembolism.

JAMA cardiology·2019
Same author

Self-related Health and Blood Hypercoagulability: A Possible Mechanism for Cardiovascular Risk.

Thrombosis and haemostasis·2018
Same journal

D-dimer testing in ischemic stroke and cerebral sinus and venous thrombosis.

Seminars in vascular medicine·2005
Same journal

D-dimer testing in pregnancy.

Seminars in vascular medicine·2005
Same journal

D-dimer levels, constitutional thrombophilia, and venous thrombosis prediction: clinical aspects and implications.

Seminars in vascular medicine·2005
Same journal

D-dimer, oral anticoagulation, and venous thromboembolism recurrence.

Seminars in vascular medicine·2005
Same journal

Screening for deep vein thrombosis and pulmonary embolism in outpatients with suspected DVT or PE by the sequential use of clinical score: a sensitive quantitative D-dimer test and noninvasive diagnostic tools.

Seminars in vascular medicine·2005
Same journal

The role of qualitative D-dimer assays, clinical probability, and noninvasive imaging tests for the diagnosis of deep vein thrombosis and pulmonary embolism.

Seminars in vascular medicine·2005
See all related articles

Fibrin D-dimer assays, used to detect blood clot formation and breakdown, are linked to cardiovascular disease risks. Further research is needed to confirm D-dimer

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Clinical Chemistry

Background:

  • Fibrin D-dimer is a key biomarker for detecting coagulation activation and fibrinolysis in blood.
  • Previous studies over 15 years have associated D-dimer levels with increased cardiovascular disease (CVD) risks.

Purpose of the Study:

  • To review the analytic, preanalytic, and clinical associations of Fibrin D-dimer.
  • To explore the role of D-dimer in various thromboembolic conditions and cardiovascular risk prediction.

Main Methods:

  • Comprehensive literature review of studies on Fibrin D-dimer and cardiovascular diseases.
  • Analysis of associations between D-dimer and risk factors, coronary heart disease, atrial fibrillation, stroke, peripheral arterial disease, and venous thromboembolism.

Related Experiment Videos

Main Results:

  • D-dimer is associated with risks of coronary heart disease, atrial fibrillation, stroke, peripheral arterial disease, and venous thromboembolism.
  • These findings suggest that activated coagulation and fibrinolysis may contribute to arterial, intracardiac, and venous thromboembolism.

Conclusions:

  • Fibrin D-dimer shows potential utility in predicting cardiovascular risk and identifying patients for anticoagulation therapy.
  • Further studies are required to validate D-dimer's clinical utility, and assay harmonization is crucial for improved clinical application.